#$%^&*AU2016204909A120160804.pdf#####TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND INTERFERON-BETA Abstract of the Disclosure This invention provides a method of treating a patient afflicted with multiple sclerosis or presenting a 5 clinically isolated syndrome comprising administering to the patient laquinimod as an add-on therapy to or in combination with interferon-P. This invention also provides a package and a pharmaceutical composition comprising laquinimod and interferon- for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with interferon- in treating a patient afflicted with multiple 0 sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and interferon- in the preparation of a combination for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome.
